Biomarin Pharmaceutical reported $-2417000 in Operating Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US USD -30866000 2.78M
Acorda Therapeutics ACOR:US USD -4989000 8.93M
Agios Pharmaceuticals AGIO:US USD -86647000 8.29M
Alnylam Pharmaceuticals ALNY:US USD -334626000 142.94M
Amgen AMGN:US USD 2.74B 562M
Bayer BAYN:GR EUR 1.2B 1.03B
Biogen BIIB:US USD 1.32B 1.37B
Biomarin Pharmaceutical BMRN:US USD -2417000 41.57M
Bluebird Bio BLUE:US USD -84781000 22.62M
Gilead Sciences GILD:US USD 2.84B 808M
Insmed INSM:US USD -127697000 39.38M
Intercept Pharmaceuticals ICPT:US USD -101903000 88.54M
IONIS PHARMACEUT IONS:US USD -59154000 26.36M
Moderna Inc MRNA:US USD 1.17B 1.28B
Neurocrine Biosciences NBIX:US USD 87.8M 103.1M
Ptc Therapeutics PTCT:US USD -68187000 24.17M
Puma Biotechnology PBYI:US USD 2.39M 9.61M
Regeneron Pharmaceuticals REGN:US USD 1.22B 113.8M
Sangamo Biosciences SGMO:US USD -54894000 9.16M
Sarepta Therapeutics SRPT:US USD -256796000 45.66M
Seattle Genetics SGEN:US USD -192805000 59.69M
Ultragenyx Pharmaceutical RARE:US USD -225066000 83.47M
United Therapeutics UTHR:US USD 314.3M 112.5M
Vertex Pharmaceuticals VRTX:US USD 1.13B 20.4M
YTE INCY:US USD 138.38M 116.06M